Published • loading... • Updated
Permira seeks $4 billion for sale of contract drugmaker Cambrex, FT reports
Summary by Reuters
4 Articles
4 Articles
Permira seeks $4 billion for sale of contract drugmaker Cambrex, FT reports
British private equity firm Permira has put its contract drugmaker Cambrex up for sale, targeting a valuation of as much as $4 billion, the Financial Times reported on Saturday, citing people familiar with the matter.
·United Kingdom
Read Full ArticleCoverage Details
Total News Sources4
Leaning Left0Leaning Right0Center4Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium